Answers are grounded in this paper and cite their sources.
Altered hepatic function tests occurred in four of 25 patients treated with valproic acid. An average dose reduction in three patients of 10 mg per kilogram per day resulted in reversion of serum glutamic oxaloacetic transaminase (SGOT) and serum glutamic pyruvic transaminase (SGPT) to normal. The drug was discontinued in one patient. Careful monitoring of hepatic function is required of patients being treated with valproic acid, but our experience suggests that dose reduction alone may be effective in preventing untoward hepatic side effects.
No takes yet. Share an insight, caveat, or question.
Willmore et al. (1978) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: